AChE/Aβ-IN-5

Compound AV-2 (AChE/Aβ-IN-5) is a dual-action small molecule inhibitor targeting acetylcholinesterase (AChE) and amyloid-β (Aβ) aggregation. It has shown efficacy in reducing cognitive deficits in scopolamine- and Aβ-induced mouse models, supporting its use in Alzheimer's disease research for both in vitro and in vivo experimental applications.